Tag: Medicare drug negotiation

How Buyers Use Generic Competition to Negotiate Lower Drug Prices

How Buyers Use Generic Competition to Negotiate Lower Drug Prices

Buyers like Medicare use the presence of generic drugs to negotiate lower prices for brand-name medications. Generic competition drives prices down by over 90% in many cases, making it a key tool for controlling drug costs.

Recent Posts

How Medicare Drug Price Negotiations Work and What It Means for Insurer Discounts
Dec, 29 2025
How Medicare Drug Price Negotiations Work and What It Means for Insurer Discounts

Medicare can now negotiate drug prices for the first time under the Inflation Reduction Act. Discover how this cuts costs for seniors, changes insurer discounts, and reshapes the entire U.S. drug pricing system.

Diet Tips to Keep Estradiol Levels Healthy
Oct, 23 2025
Diet Tips to Keep Estradiol Levels Healthy

Learn practical diet and nutrition strategies to keep estradiol levels balanced, covering phytoestrogens, omega‑3s, vitamin D, fiber and more.

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
Dec, 5 2025
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers

The FDA uses Import Alerts to automatically block drug shipments from non-compliant manufacturers. With the 2025 Green List initiative, enforcement against GLP-1 APIs has become the strictest in history-reshaping global supply chains and raising compliance standards.

Levothyroxine with Iron and Calcium: How to Separate Doses for Maximum Effectiveness
Dec, 15 2025
Levothyroxine with Iron and Calcium: How to Separate Doses for Maximum Effectiveness

Learn how to properly separate levothyroxine from iron and calcium supplements to ensure your thyroid medication works effectively. Avoid dangerous interactions with clear timing rules and practical tips.

How Autonomous Vehicles Could Shape Future Traffic Congestion
Sep, 30 2025
How Autonomous Vehicles Could Shape Future Traffic Congestion

Explore how self‑driving cars could reshape traffic jams, the tech behind them, policy levers, real‑world pilots, and what it means for commuters and cities.